Oral contraceptive use in women at increased risk of breast/ovarian cancer: knowledge and attitudes
Bui, K.T.; Wakefield, C.E.; Kasparian, N.A.; Tyler, J.; Abbott, J.; Tucker, K.
Psycho-Oncology 22(1): 228-232
2013
ISSN/ISBN: 1099-1611 PMID: 21905159 DOI: 10.1002/pon.2049Document Number: 551904
Several of the health benefits and risks associated with the combined oral contraceptive pill (COCP) are particularly relevant to women at risk of hereditary breast and/or ovarian cancer. Eighty-three past female patients of an Australian hereditary cancer clinic aged 18-50 years completed a self-report questionnaire to assess their contraceptive practices, knowledge and information needs (44% response rate). Ninety-two percent of participants had previously used the COCP, with a mean knowledge score of 3.63 out of 8. Nearly 40% reported that their family history of cancer was one reason they discontinued/avoided using the COCP. Women reported receiving insufficient COCP information and preferred a targeted information leaflet to answer their questions. Although recall bias may have affected some women, there is a clear need to improve the consistency of information delivered to women at risk of hereditary breast and/or ovarian cancer, to ensure informed contraceptive choices are made.